-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Lowers Price Target to $265

Benzinga·02/13/2026 17:53:13
Listen to the news
Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and lowers the price target from $325 to $265.